medigraphic.com
SPANISH

Revista Mexicana de Cirugía Pediátrica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 4

<< Back

Rev Mex Cir Pediatr 2008; 15 (4)

Aspergilloma as an uncommon cause of pleural effusion in Pediatrics

Garcia-Maldonado S, Hernandez-Flota A, Vasquez-Contreras JA, Tolosa-Kuk M, Canche-Duran D, Rodriguez-Moguel LC
Full text How to cite this article

Language: Spanish
References: 6
Page: 193-196
PDF size: 174.77 Kb.


Key words:

aspergillosis, pulmonary aspergilloma, pleural effusion, fungal infection.

ABSTRACT

Introduction: Aspergillosis occurs as a result of inhalation of the spores contained in the air. For the diagnosis of the disease is important to have clinical data to identify a history of any residual disease that causes cavities or bronchiectasis.
Clinical Case Presentation: Men of five years beginning five days before admission with fever and vomiting unquantified food and giving amoxicillin loratadine without improvement, two days before admission is associated with productive cough in fits. Chest Rx was making a left pleural effusion was found.
Discussion: Pulmonary aspergilloma can be defined as a conglomeration of hyphae of Aspergillus, with mucus, fibrin and cellular debris in a lung cavity or bronchi, the most common symptom of hemoptysis is present in up to 50% to 80% of patients, however, in our patient the symptoms were cough and progressive dyspnea. Also reported in the literature as the unusual presence of fever, a symptom in our patient was detected in the primary. There is no consensus on medical treatment of aspergilloma, as there are different methods for this in the literature.


REFERENCES

  1. Kenneth W. Gow, Andrea A. Hayes-Jordan, etal: Benefit of Surgical Resection of Invasive Pulmonary Aspergillosis in Pediatric Patients Undergoing Treatment for Malignancies and Immunodeficiency Síndromes. Journal of Pediatric Surgery, Vol 38, No 9 (September), 2003: pp 1354-1360.

  2. Raoul Herbrecht, M.D.,Shanti Natarajan- Ame M.D.Valerie Letscher-Bru et al Invasive Pulmonary Aspergillosis, Seminars in Respiratory and Critical Care Medicine/Volume 25, Number 2 2004.

  3. Marc A. Judson, M.D, Noninvasive Aspergillus Pulmonary Disease, Seminars in Respiratory and Critical Care Medicine/Volume 25, Number 2 2004

  4. Young V, Maghur H, Luke D, et al: Operationfor cavitating invasive pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 53:621-624, 1992.

  5. Patterson TF, Kirkpatrick WR, White M, et al: Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79:250-260, 2000.

  6. Janssen J, Strack van Schijndel R, van der Poest C, et al: Outcome of ICU treatment in invasive aspergillosis. Int Care Med 22:1315-1322, 1996.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cir Pediatr. 2008;15